TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo, Japan; hereinafter referred to as “Elix”) has ...
The selection of diverse versus targeted compound libraries shapes the balance between exploring novel chemical space and interrogating known biological targets. The diversity-oriented vs focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results